Abstract:Photodynamic therapy (PDT) is a clinically approved therapeutic modality that has shown great potential for the treatment of cancers owing to its excellent spatiotemporal selectivity and inherently noninvasive nature. However, PDT has not reached its full potential, partly due to the lack of ideal photosensitizers. A common molecular design strategy for effective photosensitizers is to incorporate heavy atoms into photosensitizer structures, causing concerns about elevated dark toxicity, short triplet-state lifetimes, poor photostability, and the potentially high cost of heavy metals. To address these drawbacks, a significant advance has been devoted to developing advanced smart photosensitizers without the use of heavy atoms to better fit the clinical requirements of PDT. Over the past few years, heavy-atom-free nonporphyrinoid photosensitizers have emerged as an innovative alternative class of PSs due to their superior photophysical and photochemical properties and lower expense. Heavy-atom-free nonporphyrinoid photosensitizers have been widely explored for PDT purposes and have shown great potential for clinical oncologic applications. Although many review articles about heavy-atom-free photosensitizers based on porphyrinoid structure have been published, no specific review articles have yet focused on the heavy-atom-free nonporphyrinoid photosensitizers.In this account, the specific concept related to heavy-atom-free photosensitizers and the advantageous properties of heavy-atom-free photosensitizers for cancer theranostics will be briefly introduced. In addition, recent progress in the development of heavy-atom-free photosensitizers, ranging from molecular design approaches to recent innovative types of heavy-atom-free nonporphyrinoid photosensitizers, emphasizing our own research, will be presented. The main molecular design approaches to efficient heavy-atom-free PSs can be divided into six groups: (1) the approach based on traditional tetrapyrrole structures, (2) spin-orbit charge-transfer intersystem crossing (SOCT-ISC), (3) reducing the singlet-triplet energy gap (Δ<i>E</i><sub>ST</sub>), (4) the thionation of carbonyl groups of conventional fluorophores, (5) twisted π-conjugation system-induced intersystem crossing, and (6) radical-enhanced intersystem crossing. The innovative types of heavy-atom-free nonporphyrinoid photosensitizers and their applications in cancer diagnostics and therapeutics will be discussed in detail in the third section. Finally, the challenges that need to be addressed to develop optimal heavy-atom-free photosensitizers for oncologic photodynamic therapy and a perspective in this research field will be provided. We believe that this review will provide general guidance for the future design of innovative photosensitizers and spur preclinical and clinical studies for PDT-mediated cancer treatments.

Internal Heavy Atom Effect of Au(III) and Pt(IV) on Hypocrellin A for Enhanced in Vitro Photodynamic Therapy of Cancer.

Heavy Atom Effect on Water-Soluble Porphyrin Photosensitizers for Photodynamic Therapy

BODIPY-based Monofunctional Pt (II) Complexes for Specific Photocytotoxicity Against Cancer Cells

Correction To: Carbon Dots @ Platinum Porphyrin Composite As Theranostic Nanoagent for Efficient Photodynamic Cancer Therapy

Biocompatible hypocrellin A-Fe( iii ) nanoparticles exhibiting efficient photo-activated CDT in vitro and in vivo

Enhanced photocytotoxicity induced by a triphenylphosphonium-appended platinum diimine complex

Heavy-Atom-Free Photosensitizers: From Molecular Design to Applications in the Photodynamic Therapy of Cancer

Precise ligand engineering of Ir(III)-based photosensitizer with aggregation-induced emission for image-guided photodynamic therapy

Influence of Parameters on Photodynamic Therapy of Au@TiO2–HMME Core-Shell Nanostructures

Photophysical properties of Pt(II) and Pd(II) complexes for two-photon photodynamic therapy: A computational investigation

A New Approach to Sensitize Antitumor Monofunctional Platinum(II) Complexes Via Short Time Photo-Irradiation.

Electrostatic Self-Assembled Iridium(III) Nano-Photosensitizer for Selectively Disintegrated and Mitochondria Targeted Photodynamic Therapy

Light Amplified Oxidative Stress in Tumor Microenvironment by Carbonized Hemin Nanoparticles for Boosting Photodynamic Anticancer Therapy

An AIEgen and Iodine Double-Ornamented Platinum(II) Complex for Bimodal Imaging-Guided Chemo-Photodynamic Combination Therapy

Supramolecular coordination complexes (SCCs) with aggregation-induced emission for in vitro photodynamic therapy

An AIE Metal Iridium Complex: Photophysical Properties and Singlet Oxygen Generation Capacity

Au Nanoclusters and Photosensitizer Dual Loaded Spatiotemporal Controllable Liposomal Nanocomposites Enhance Tumor Photodynamic Therapy Effect by Inhibiting Thioredoxin Reductase

Anti-tumor evaluation of a novel methoxyphenyl substituted chlorin photosensitizer for photodynamic therapy

Photosubstitution and photoreduction of a diazido platinum(IV) anticancer complex

A Pair of Deep Red Phosphorescent Responsive Emissive Cyclometalated Iridium (III) Complexes as Carbonic Anhydrase Inhibitor and Effective Theranostic Photosensitizer

A Photodynamic and Photochemotherapeutic Platinum‐Iridium Charge‐Transfer Conjugate for Anticancer Therapy